Trial Profile
Enhancement of Corticosteroid Efficacy in COPD
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary) ; Theophylline (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 16 Aug 2016 Status changed from recruiting to completed.
- 19 Jan 2015 New trial record